Baseline characteristics

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma · Source last updated 2016-08-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      384

   2. group Id

      BG001

      value

      193

   3. group Id

      BG002

      value

      577

   units

   Participants

groups

1. description

   Trabectedin at a dose of 1.5 milligram per meter square (mg/m\^2) was given as an intravenous (IV) infusion over 24-hour every 3 weeks on Day 1 of every cycle (21 days) until disease progression. Dexamethasone 20 mg IV was also administered within 30 minutes before start of each trabectedin infusion.

   id

   BG000

   title

   Trabectedin

2. description

   Dacarbazine at a dose of 1 gram per meter square (mg/m\^2) was given as an intravenous (IV) infusion over 20-120 minutes every 3 weeks on Day 1 of every cycle (21 days) until disease progression. Dexamethasone 20 mg IV was also administered within 30 minutes before start of each dacarbazine infusion.

   id

   BG001

   title

   Dacarbazine

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            11.04

            value

            56.5

         2. group Id

            BG001

            spread

            11.92

            value

            54.1

         3. group Id

            BG002

            spread

            11.39

            value

            55.7

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            262

         2. group Id

            BG001

            value

            140

         3. group Id

            BG002

            value

            402

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            122

         2. group Id

            BG001

            value

            53

         3. group Id

            BG002

            value

            175

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            15

         2. group Id

            BG001

            value

            8

         3. group Id

            BG002

            value

            23

      title

      AUS

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            10

         2. group Id

            BG001

            value

            2

         3. group Id

            BG002

            value

            12

      title

      BRA

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            3

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            3

      title

      NZL

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            356

         2. group Id

            BG001

            value

            183

         3. group Id

            BG002

            value

            539

      title

      USA

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice